Booth C - Search Results

1

The rise of immuno-oncology in China: a challenge to western dominance?

Lythgoe MP, Lewison G, Aggarwal A, Booth C, Lawler M, Trapani D, Sengar M, Sullivan R. Lythgoe MP, et al. Among authors: booth c. Lancet Oncol. 2023 May;24(5):439-441. doi: 10.1016/S1470-2045(23)00026-8. Lancet Oncol. 2023. PMID: 37142369 No abstract available.

2

Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?

Booth CM, Tannock I. Booth CM, et al. J Clin Oncol. 2008 Jan 1;26(1):6-8. doi: 10.1200/JCO.2007.13.8156. J Clin Oncol. 2008. PMID: 18165630 Review. No abstract available.

3

Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?

Del Paggio JC, Azariah B, Sullivan R, Hopman WM, James FV, Roshni S, Tannock IF, Booth CM. Del Paggio JC, et al. Among authors: booth cm. Ann Oncol. 2017 Jan 1;28(1):157-162. doi: 10.1093/annonc/mdw538. Ann Oncol. 2017. PMID: 27742650 Free article.

4

Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.

Del Paggio JC, Sullivan R, Schrag D, Hopman WM, Azariah B, Pramesh CS, Tannock IF, Booth CM. Del Paggio JC, et al. Among authors: booth cm. Lancet Oncol. 2017 Jul;18(7):887-894. doi: 10.1016/S1470-2045(17)30415-1. Epub 2017 Jun 2. Lancet Oncol. 2017. PMID: 28583794

5

Five years of EMA-approved systemic cancer therapies for solid tumours-a comparison of two thresholds for meaningful clinical benefit.

Grössmann N, Del Paggio JC, Wolf S, Sullivan R, Booth CM, Rosian K, Emprechtinger R, Wild C. Grössmann N, et al. Among authors: booth cm. Eur J Cancer. 2017 Sep;82:66-71. doi: 10.1016/j.ejca.2017.05.029. Epub 2017 Jul 10. Eur J Cancer. 2017. PMID: 28648700 Free article.

6

Cancer patients need better care, not just more technology.

Sullivan R, Pramesh CS, Booth CM. Sullivan R, et al. Among authors: booth cm. Nature. 2017 Sep 19;549(7672):325-328. doi: 10.1038/549325a. Nature. 2017. PMID: 28933447 No abstract available.

7

Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies.

Del Paggio JC, Sullivan R, Hopman WM, Booth CM. Del Paggio JC, et al. Among authors: booth cm. Ann Oncol. 2018 Mar 1;29(3):773-774. doi: 10.1093/annonc/mdx721. Ann Oncol. 2018. PMID: 29112709 Free article. No abstract available.

8

Targeting the value of targeted therapy.

Paggio JCD, Sullivan R, Booth CM. Paggio JCD, et al. Among authors: booth cm. Oncotarget. 2017 Oct 7;8(53):90612-90613. doi: 10.18632/oncotarget.21596. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207580 Free PMC article. No abstract available.

9

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload.

Fundytus A, Sullivan R, Vanderpuye V, Seruga B, Lopes G, Hammad N, Sengar M, Hopman WM, Brundage MD, Booth CM. Fundytus A, et al. J Glob Oncol. 2018 Sep;4(4):1-11. doi: 10.1200/JGO.17.00126. Epub 2017 Dec 15. J Glob Oncol. 2018. PMID: 29244632 Free PMC article.

10

Cancer groundshot: going global before going to the moon.

Gyawali B, Sullivan R, Booth CM. Gyawali B, et al. Lancet Oncol. 2018 Mar;19(3):288-290. doi: 10.1016/S1470-2045(18)30076-7. Lancet Oncol. 2018. PMID: 29508746 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,610 results

Search Page

Filters